Will Alaynick

Will Alaynick is a seasoned entrepreneur and co-founder with extensive experience in the life sciences sector. As Co-Founder and Managing Partner at Phase Two Ventures since January 2023, Alaynick focuses on seed-stage investing in life science R&D. Alaynick co-founded Defined Bioscience in December 2019, which specializes in chemically defined, animal product-free cell culture media. Additionally, Alaynick played a pivotal role in founding NanoCellect Biomedical in 2009 and Arima Genomics in 2015, both aimed at advancing life sciences through innovative technologies. Alaynick's earlier career includes significant research roles at prestigious institutions, including the Howard Hughes Medical Institute, and participation on various advisory boards. Educational credentials include a PhD in Biomedical Sciences from UC San Diego and a postdoctoral fellowship in Developmental Neurobiology from The Salk Institute.